
102 - Sustainable Clinical Trials (1): Christian Hieronimi on Convien & myoncare
The Sustainable Healthcare PodcastShow Notes
The first episode of our Sustainable Clinical Trials mini-series, produced in partnership with the Sustainable Healthcare Coalition (SHC), following up on the Community of Practice conference in London on 4 November 2025. Each episode brings one of the CoP speakers back to share their story in long form.
GUEST Christian Hieronimi, Founder & CEO of ONCARE (myoncare) and co-founder of Convien. A serial healthcare entrepreneur based in Munich, with previous exits to Elekta (Medical Intelligence) and Varian (humediq).
WHAT YOU WILL LEARN How Convien's meeting-point optimiser can cut around 30 to 35% of travel cost and 40% of the CO2 footprint of investigator meetings, by jointly optimising ticket price, travel time and carbon per kilogram. Why roughly half of corporate travel spend in international organisations is driven by meetings, not customer visits, and why that makes meetings the biggest under-addressed decarbonisation lever in clinical operations. How myoncare uses wearable data, symptom questionnaires and guideline-based thresholds to "fill the void" between doctor visits, and how the same platform can decentralise a trial by routing blood work, imaging and eligibility checks to local providers.
TIMESTAMPS 00:00 Introduction by Nathalie Preiswerk (Sustainable Healthcare Coalition) and series framing 02:00 Meet Christian: serial founder, robotics and oncology background 03:30 Convien origin story: Beijing vs. Barcelona, 2010 06:00 The three-variable optimisation: cost, time, carbon 10:00 How big is the meetings prize inside corporate travel 11:00 Applying Convien to investigator meetings and site selection 13:00 Introducing myoncare: a care orchestration platform 16:00 A chronic kidney disease use case, end to end 20:00 Decentralised trials: bringing the site to the patient 22:00 Bring-your-own-device and the International Patient Summary 25:00 Care pathways that trigger the next step automatically
REFERENCES MENTIONED Sustainable Healthcare Coalition Community of Practice conference (London, 4 Nov 2025): https://shcoalition.org/cop-conference/ SHC Sustainable Clinical Trials Knowledge Hub: https://shcoalition.org/sustainable-clinical-trials-knowledge-hub/ Convien Smart Meeting Location Planner: https://www.convien.com/ myoncare Virtual coordinated care: https://www.myoncare.com/ Convien Meeting Point Optimiser (Siemens partnership, Microsoft AppSource): https://marketplace.microsoft.com/en-us/product/office/wa200001588 EU MDR 2017/745 (myoncare is classified as MDR Class IIa) International Patient Summary (ISO 27269)
CONNECT WITH THE GUEST Christian Hieronimi on LinkedIn: https://www.linkedin.com/in/christian-hieronimi-066a394/ ONCARE / myoncare: https://www.myoncare.com/ Convien GmbH: https://www.convien.com/
YOU MIGHT ALSO ENJOY 091 SHC: the Sustainable Healthcare Coalition (Fiona Adshead, Keith Moore, Nathalie Preiswerk), the backstory to this mini-series. 089 Koen Kas on transforming healthcare and clinical trials, another conversation on reimagining the trial operating model. 083 Sustainability requirements in public procurement, relevant if you are thinking about where the buy-side pressure lands.
HOSTS Joachim Almdal on LinkedIn: https://www.linkedin.com/in/joachim-espeland-almdal-017a6973/ Frederik van Deurs on LinkedIn: https://www.linkedin.com/in/frederikvandeurs/ Care Pathway Consulting: https://carepathwayconsulting.com
PULL QUOTE "In between two doctor's visits, nobody looks after the patient, because the patient's pretty much invisible. We are filling up that void." Christian Hieronimi
Produced in partnership with the Sustainable Healthcare Coalition.
More from The Sustainable Healthcare Podcast
Most work on greener medication starts with the waste bin. This episode goes one step upstream, to the moment a medicine is prescribed at all, and in which form. Lisa-Marie Smale and Nicole Hunfeld explain what 63 Dutch doctors and pharmacists agreed to change about prescribing, why a tablet can beat a drip, and where a stop date gets lost on the way home.
Hospitals use many single-use products.
What happens when you move acute hospital care into the patient's own home? Maria Normand Larsen shares the results of Denmark's first hospital-at-home randomised trial.
If we want to fix sustainability in healthcare, one of the most powerful levers sits at the gate where new health technologies get approved: Health Technology Assessment (HTA).
How do you cut 40% of the carbon out of a clinical trial without changing the price? You rent the equipment instead of buying it.